Literature DB >> 2464529

Biosynthesis and analysis of a genetically engineered HIV-1 reverse transcriptase/endonuclease polyprotein in Escherichia coli.

A Leuthardt1, S F Le Grice.   

Abstract

Elimination of the protease domain from the polymerase open reading frame (pol) of the human immunodeficiency virus type 1 (HIV-1) leads, in Escherichia coli, to synthesis and accumulation of a non-processed 98-kDa reverse transcriptase/endonuclease (RT/ENDO) polyprotein. A partially purified preparation of this reverse RT/ENDO polyprotein displays little or no RT activity. Introduction of the pol protease domain as a separate transcriptional unit on the same plasmid restores the processing program, generating correctly sized RT and ENDO polypeptides. Concomitant with restoration of processing is the reappearance of RT activity. These results suggest that for HIV-1 RT to be active, it must be matured from the pol polyprotein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2464529     DOI: 10.1016/0378-1119(88)90596-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  14 in total

1.  Properties of avian retrovirus particles defective in viral protease.

Authors:  L Stewart; G Schatz; V M Vogt
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Enzyme activities in four different forms of human immunodeficiency virus 1 pol gene products.

Authors:  Y W Hu; C Y Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Reverse transcriptase and protease activities of avian leukosis virus Gag-Pol fusion proteins expressed in insect cells.

Authors:  L Stewart; V M Vogt
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

4.  Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.

Authors:  Michael E Abram; Michael A Parniak
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Site-specific inhibition of RNA polymerase II preinitiation complex assembly by human cytomegalovirus IE86 protein.

Authors:  J Wu; R Jupp; R M Stenberg; J A Nelson; P Ghazal
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.

Authors:  L Stewart; V M Vogt
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants.

Authors:  C T Wang; E Barklis
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box.

Authors:  R Jupp; S Hoffmann; A Depto; R M Stenberg; P Ghazal; J A Nelson
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

9.  Major antigenic region on the integrase (IN) protein of human immunodeficiency virus type 1 determined by reactivity of human sera and a monoclonal antibody to IN protein.

Authors:  Y Tachibana; A Yasuda; T Kurata; S Oka; K Shimada; A Kojima
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

10.  Human T-cell leukemia virus type 1 reverse transcriptase (RT) originates from the pro and pol open reading frames and requires the presence of RT-RNase H (RH) and RT-RH-integrase proteins for its activity.

Authors:  B Trentin; N Rebeyrotte; R Z Mamoun
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.